Tokyo Tape
Sign in
← PHC Holdings

Quarterly report · Q3

6523.TEDINET S100SW3M
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥256.7bn2023-04-01 → 2023-12-31Cons.Revenue IFRS
Revenue¥89.9bn2023-10-01 → 2023-12-31dCons.Revenue IFRS
Revenue¥356.4bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥265.1bn2022-04-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥94.5bn2022-10-01 → 2022-12-31dCons.Revenue IFRS
Operating income−¥5.1bn2023-04-01 → 2023-12-31Cons.Operating profit loss IFRS
Operating income−¥9.3bn2023-10-01 → 2023-12-31dCons.Operating profit loss IFRS
Operating income¥21.4bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥10.9bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Profit before tax−¥13.8bn2023-04-01 → 2023-12-31Cons.Profit loss before tax IFRS
Profit before tax−¥10.7bn2023-10-01 → 2023-12-31dCons.Profit loss before tax IFRS
Profit before tax¥179m2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥7.4bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥4.0bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Net income (owners)−¥11.2bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥8.7bn2023-10-01 → 2023-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥3.2bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥3.4bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥2.2bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income−¥11.2bn2023-04-01 → 2023-12-31Cons.Profit loss IFRS
Net income−¥8.7bn2023-10-01 → 2023-12-31dCons.Profit loss IFRS
Net income¥3.6bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥2.2bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Total assets¥541.0bnat 2023-12-31Cons.Assets IFRS
Total assets¥561.6bnat 2023-03-31Cons.Assets IFRS
Total assets¥569.9bnat 2022-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥416.7bnat 2023-12-31Cons.Liabilities IFRS
Total liabilities¥422.7bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥124.3bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥138.8bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥138.8bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥136.1bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥124.7bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥138.0bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥137.9bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥43.9bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥60.9bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥59.4bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥95.2bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥28.5bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥21.4bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥6.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥17.1bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥17.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥11.3bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥31.1bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥40.8bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥32.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-88.72023-04-01 → 2023-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥-69.072023-10-01 → 2023-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥-25.842022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥27.332022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥17.692022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥-88.72023-04-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-69.072023-10-01 → 2023-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥-25.842022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥27.072022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥17.532022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio23.0%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.6%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.2%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31¥1.8bn
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-12-31¥1.8bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥7.3bn
jpcrp040300-q3r_E36976-000Diabetes Managementreportable segmentrevenue2023-04-01 → 2023-12-31¥80.3bn
jpcrp040300-q3r_E36976-000Diabetes Managementreportable segmentrevenue external2023-04-01 → 2023-12-31¥80.3bn
jpcrp040300-q3r_E36976-000Diabetes Managementreportable segmentsegment profit2023-04-01 → 2023-12-31¥8.8bn
jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2023-04-01 → 2023-12-31¥79.4bn
jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2023-04-01 → 2023-12-31¥79.4bn
jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2023-04-01 → 2023-12-31¥4.9bn
jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segmentrevenue2023-04-01 → 2023-12-31¥95.2bn
jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segmentrevenue external2023-04-01 → 2023-12-31¥95.2bn
jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segmentsegment profit2023-04-01 → 2023-12-31−¥11.6bn
—segment totalrevenue2023-04-01 → 2023-12-31¥254.9bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥254.9bn
—segment totalsegment profit2023-04-01 → 2023-12-31¥2.1bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31¥1.8bn
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-12-31¥1.8bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥13.0bn
jpcrp040300-q3r_E36976-000Diabetes Managementreportable segmentrevenue2022-04-01 → 2022-12-31¥83.7bn
jpcrp040300-q3r_E36976-000Diabetes Managementreportable segmentrevenue external2022-04-01 → 2022-12-31¥83.7bn
jpcrp040300-q3r_E36976-000Diabetes Managementreportable segmentsegment profit2022-04-01 → 2022-12-31¥19.7bn
jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2022-04-01 → 2022-12-31¥80.4bn
jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2022-04-01 → 2022-12-31¥80.4bn
jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2022-04-01 → 2022-12-31¥6.3bn
jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segmentrevenue2022-04-01 → 2022-12-31¥99.2bn
jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segmentrevenue external2022-04-01 → 2022-12-31¥99.2bn
jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segmentsegment profit2022-04-01 → 2022-12-31¥8.5bn
—segment totalrevenue2022-04-01 → 2022-12-31¥263.3bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥263.3bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥34.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 875
ItemContextValueUnit
Cash and cash equivalents IFRS (5-year summary)Prior1YearInstant60933000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember126139556
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember126184396
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant126139556
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant126184396
Number of shares issued shares voting rightsCurrentQuarterInstant_jpcrp040300-q3r_E36976-000ClassASharesSharesWithNoVotingRightsMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember211900
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember125894600
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember1258946
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember33056
Number of shares issued shares voting rightsCurrentQuarterInstant126139556
Number of voting rights issued shares voting rightsCurrentQuarterInstant1258946
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member211900
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member211900
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0017
Number of shares held in own name treasury shares etcCurrentQuarterInstant211900
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant211900
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0017
Cash and cash equivalents IFRSPrior1YearInstant60933000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant43902000000JPY
Trade receivables ca IFRSPrior1YearInstant69280000000JPY
Trade receivables ca IFRSCurrentQuarterInstant63510000000JPY
Inventories ca IFRSPrior1YearInstant51732000000JPY
Inventories ca IFRSCurrentQuarterInstant56572000000JPY
Other financial assets ca IFRSPrior1YearInstant2321000000JPY
Other financial assets ca IFRSCurrentQuarterInstant3766000000JPY
Other current assets ca IFRSPrior1YearInstant13314000000JPY
Other current assets ca IFRSCurrentQuarterInstant8845000000JPY
Current assets IFRSPrior1YearInstant197583000000JPY
Current assets IFRSCurrentQuarterInstant176597000000JPY
Property plant and equipment IFRSPrior1YearInstant47593000000JPY
Property plant and equipment IFRSCurrentQuarterInstant46437000000JPY
Goodwill IFRSPrior1YearInstant199707000000JPY
Goodwill IFRSCurrentQuarterInstant200225000000JPY
Intangible assets IFRSPrior1YearInstant91123000000JPY
Intangible assets IFRSCurrentQuarterInstant89901000000JPY
Investments accounted for using equity method IFRSPrior1YearInstant3697000000JPY
Investments accounted for using equity method IFRSCurrentQuarterInstant2127000000JPY
Other financial assets nca IFRSPrior1YearInstant16107000000JPY
Other financial assets nca IFRSCurrentQuarterInstant13885000000JPY
Deferred tax assets IFRSPrior1YearInstant4425000000JPY
Deferred tax assets IFRSCurrentQuarterInstant8225000000JPY
Other non current assets nca IFRSPrior1YearInstant1328000000JPY
Other non current assets nca IFRSCurrentQuarterInstant3563000000JPY
Non current assets IFRSPrior1YearInstant363984000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2023-10-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass